3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
74
Colonic Neoplasms
24
Colonic Polyps
15
Adenoma
14
Neoplasms
5
Colorectal Neoplasms, Hereditary Nonpolyposis
5
Polyps
4
Pain
4
Gastrointestinal Neoplasms
4
Disease
4
Adenomatous Polyps
3
Stomach Neoplasms
2
Peptic Ulcer
2
Liver Cirrhosis
2
Intestinal Neoplasms
2
Intestinal Diseases
2
Inflammatory Bowel Diseases
2
Gastritis, Atrophic
2
Digestive System Diseases
2
Colitis, Ulcerative
2
Turcot syndrome
1
Tuberculosis
1
Signs and Symptoms, Digestive
1
Recurrence
1
Rectal Neoplasms
1
Rectal Diseases
1
Predictive Cancer Model
1
Personal Satisfaction
1
Patient Satisfaction
1
Pathologic Complete Response
1
Interventions
Cyclophosphamide
4
Gemcitabine
3
isatuximab
2
entrectinib
2
cobimetinib
2
capmatinib
2
atezolizumab
2
anlotinib
2
alectinib
2
Vemurafenib
2
Sunitinib
2
Rituximab
2
Lenalidomide
2
Dexamethasone
2
Cisplatin
2
trametinib
1
spartalizumab
1
pomalidomide
1
pertuzumab
1
penpulimab
1
pembrolizumab
1
olaparib
1
niraparib
1
lutetium Lu 177 dotatate
1
ibritumomab tiuxetan
1
fludarabine
1
dabrafenib
1
copper dotatate CU-64
1
Trastuzumab
1
Taxes
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasms by Histologic Type
×
Colonoscopy
×
Clear all
NCT04287335
2020-12-08
CLEAR-C
Zhejiang University
Completed
4,758 enrolled